Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally.
The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems.
It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence.
The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system.
In addition, it offers surpass surgical and percutaneous leads.
The company sells its products through its direct sales force, and a network of sales agents and independent distributors.
Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 24 | -0.70 Increased by +28.57% | -1.05 Increased by +33.33% |
| Feb 21, 24 | -0.25 Increased by +53.70% | -0.49 Increased by +48.98% |
| Nov 1, 23 | -0.65 Decreased by -129.28% | -0.77 Increased by +15.58% |
| Aug 1, 23 | -0.69 Increased by +2.82% | -0.69 |
| Apr 26, 23 | -0.98 Increased by 0.00% | -1.04 Increased by +5.77% |
| Feb 16, 23 | -0.54 Increased by +37.21% | -0.49 Decreased by -10.20% |
| Nov 2, 22 | 2.22 Increased by +358.14% | -0.10 Increased by +2.32 K% |
| Aug 3, 22 | -0.71 Decreased by -14.52% | -0.82 Increased by +13.41% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 103.86 M Increased by +3.38% | -23.48 M Decreased by -128.81% | Decreased by -22.61% Decreased by -127.86% |
| Jun 30, 23 | 108.81 M Increased by +4.41% | -24.72 M Increased by +1.06% | Decreased by -22.72% Increased by +5.24% |
| Mar 31, 23 | 96.33 M Increased by +9.66% | -35.03 M Decreased by -2.05% | Decreased by -36.36% Increased by +6.94% |
| Dec 31, 22 | 113.84 M Increased by +10.79% | -19.19 M Increased by +36.31% | Decreased by -16.86% Increased by +42.51% |
| Sep 30, 22 | 100.47 M Increased by +7.79% | 81.51 M Increased by +262.77% | Increased by +81.13% Increased by +251.01% |
| Jun 30, 22 | 104.21 M Increased by +1.84% | -24.99 M Decreased by -15.75% | Decreased by -23.98% Decreased by -13.66% |
| Mar 31, 22 | 87.84 M Decreased by -0.87% | -34.33 M Decreased by -16.12% | Decreased by -39.08% Decreased by -17.13% |
| Dec 31, 21 | 102.76 M Decreased by -6.35% | -30.13 M Decreased by -322.70% | Decreased by -29.32% Decreased by -351.37% |